NETWORK PHARMACOLOGY AND MOLECULAR DOCKING TECHNIQUES TO EXPLORE THE PHARMACOLOGICAL MECHANISM OF CATECHINS AND THEIR DERIVATIVES AGAINST METABOLIC SYNDROME
Keywords:Metabolic syndrome, Type 2 diabetes mellitus, Cardiovascular diseases, Obesity, Glutathione peroxidase 1, Tumor protein P53, Catechins
Objective: Metabolic syndrome (MetS) is one of the most prevalent disorders in both industrialized and developing nations that it is characterized by a set of risk variables that encompass abdominal obesity, dyslipidemia, hypertension, and insulin resistance MetS constitutes a collective set of cardiometabolic attributes that raise the risk of type 2 diabetes mellitus and cardiovascular diseases. Catechins possess anti-inflammatory and antioxidant effects which may provide defense against many chronic diseases. The present study attempts to associate the pharmacological benefits of catechins and their derivates against MetS using in silico approaches.
Methods: Identification of the ligands and target proteins was done using drugbank and protein-protein interaction network stitch, respectively. The ligands and proteins were docked using pyrx and the docked complexes were visualized on BIOVIA to identify the potential ligand. ADMET analysis was done for the same ligands to study their pharmacological properties.
Results: The proteins glutathione peroxidase 1 and tumor protein P53 were identified as target proteins expressed in MetS which also showed effective docking results with the ligands hesperidin and gamma-tocopherol, respectively. The study’s findings concurred with those of earlier studies indicating that the derivatives of catechins such as hesperidin and gamma-tocopherol had potential benefits in the prognosis of MetS.
Conclusion: The investigation findings concluded that the ligands hesperidin and gamma-tocopherol may be therapeutic against MetS prevention and management.
Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: Definitions and controversies. BMC Med 2011;9:48.
Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20:12.
Sherling DH, Perumareddi P, Hennekens CH. Metabolic syndrome. J Cardiovasc Pharmacol Ther 2017;22:365-7.
Mendrick DL, Diehl AM, Topor LS, Dietert RR, Will Y, La Merrill MA, et al. Metabolic syndrome and associated diseases: From the bench to the clinic. Toxicol Sci 2018;162:36-42.
Xu H, Li X, Adams H, Kubena K, Guo S. Etiology of metabolic syndrome and dietary intervention. Int J Mol Sci 2018;20:128.
Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic syndrome pathophysiology and predisposing factors. Int J Sports Med 2021;42:199-214.
Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 2017;960:1-17.
Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT,et al. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: A systematic review and modelling analysis. Lancet Child Adolesc Health 2022;6:158-70.
Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015;313:1973-4.
Krishnamoorthy Y, Rajaa S, Murali S, Rehman T, Sahoo J, Kar SS. Prevalence of metabolic syndrome among adult population in India: A systematic review and meta-analysis. PLoS One 2020;15:e0240971.
Ramesh S, Abraham RA, Sarna A, Sachdev HS, Porwal A, Khan N, et al. Prevalence of metabolic syndrome among adolescents in India: A population-based study. BMC Endocr Disord 2022;22:258.
Prabhakaran D, Chaturvedi V, Shah P, Manhapra A, Jeemon P, Shah B, et al. Differences in the prevalence of metabolic syndrome in urban and rural India: A problem of urbanization. Chronic Illn 2007;3:8-19.
Trivedi T, Liu J, Probst JC, Martin AB. The metabolic syndrome: Are rural residents at increased risk? J Rural Health 2013;29:188-97.
Baez-Duarte BG, Mendoza-Carrera F, García-Zapién A, Flores- Martínez SE, Sánchez-Corona J, Zamora-Ginez I, et al. Glutathione peroxidase 3 serum levels and GPX3 gene polymorphisms in subjects with metabolic syndrome. Arch Med Res 2014;45:375-82.
Francisqueti FV, Chiaverini LC, Dos Santos KC, Minatel IO, Ronchi CB, Ferron AJ, et al. The role of oxidative stress on the pathophysiology of metabolic syndrome. Rev Assoc Méd Bras (1992) 2017;63:85-91.
Simabuco FM, Morale MG, Pavan IC, Morelli AP, Silva FR, Tamura RE. p53 and metabolism: From mechanism to therapeutics. Oncotarget 2018;9:23780-823.
Bernatoniene J, Kopustinskiene DM. The role of catechins in cellular responses to oxidative stress. Molecules 2018;23:965.
Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome-a review. Phytochemistry 2009;70:11-24.
Sarafidis PA, Nilsson PM. The metabolic syndrome: A glance at its history. J Hypertens 2006;24:621-6.
Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis 2017;11:215-25.
Kuzuya M, Ando F, Iguchi A, Shimokata H. Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. Am J Clin Nutr 2008;87:1939-44.
Picklo MJ, Long EK, Vomhof-DeKrey EE. Glutathionyl systems and metabolic dysfunction in obesity. Nutr Rev 2015;73:858-68.
Delitala AP, Fanciulli G, Pes GM, Maioli M, Delitala G. Thyroid hormones, metabolic syndrome and its components.Endocr Metab Immune Disord Drug Targets 2017;17:56-62.
Liu X, Fan L, Lu C, Yin S, Hu H. Functional role of p53 in the regulation of chemical-induced oxidative stress. Oxid Med Cell Longev 2020;2020:6039769.
Yari Z, Movahedian M, Imani H, Alavian SM, Hedayati M, Hekmatdoost A. The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial. Eur J Nutr 2020;59:2569-77.
Yamamoto M, Suzuki A, Hase T. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 2008;54:95-8.
Jiang Q. Natural forms of Vitamin E: Metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med 2014;72:76-90.
Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008;44:1203-8.
How to Cite
Copyright (c) 2023 SAMEER SHARMA
This work is licensed under a Creative Commons Attribution 4.0 International License.